Search - tctmd.com

Displaying 301 - 320 of 722

Sort: Relevancy | Date

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Todd Neale

September 21, 2018

Presentation TCT 2018

TCT-31: Comparison of Standard Renal Denervation Procedure versus Novel Distal and Branch Vessel Procedure with Brachial Arterial Access

Presenter: Melvin D. Lobo, Ivo Petrov

September 21, 2018

Presentation TCT 2018

TCT-30: Renal Denervation Improves Cardiac Function in a Swine Model of Heart Failure

Presenter: Melvin D. Lobo, Ivo Petrov, Traci Goodchild

September 21, 2018

Presentation TCT 2018

TCT-29: Procedural and Anatomic Predictors of Response in RADIANCE-HTN SOLO: A Multicenter, Randomized, Sham-Controlled Trial Of Endovascular Ultrasound Renal Denervation

Presenter: Melvin D. Lobo, Ivo Petrov, Ajay J. Kirtane

September 21, 2018

Presentation TCT 2018

Renal Denervation: Light on the Horizon?

Presenter: Jeroen J. Bax, Stephan Windecker, Felix Mahfoud

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presenter: David E. Kandzari

May 23, 2018

News Industry News

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

May 17, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

News Daily News

Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced

Todd Neale

April 12, 2018

News Industry News

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

April 09, 2018

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

Presentation Controversies and Advances 2017

Rise, Fall And Resurrection of Renal Denervation

Presenter: Michael A. Weber

November 16, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

Advertisement

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

TCT-31: Comparison of Standard Renal Denervation Procedure versus Novel Distal and Branch Vessel Procedure with Brachial Arterial Access

TCT-30: Renal Denervation Improves Cardiac Function in a Swine Model of Heart Failure

TCT-29: Procedural and Anatomic Predictors of Response in RADIANCE-HTN SOLO: A Multicenter, Randomized, Sham-Controlled Trial Of Endovascular Ultrasound Renal Denervation

Renal Denervation: Light on the Horizon?

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

New European Hypertension Guidelines Not in Harmony With US Guidance

TCTMD’s Top 10 Most Popular Stories for May 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

TCTMD’s Top 10 Most Popular Stories for April 2018

Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

Rise, Fall And Resurrection of Renal Denervation

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content